The Predictive Value of HALP Score for Maximal Cytoreductive Surgery in Advanced-Stage Epithelial Ovarian Cancer

This record contains de-identified patient-level data and SPSS syntax supporting the manuscript “The Predictive Value of HALP Score for Maximal Cytoreductive Surgery in Advanced-Stage Epithelial Ovarian Cancer.” Data were collected consecutively at a single gynecologic oncology center between October 2022 and April 2024, 140 patients who underwent primary cytoreductive surgery. Variables include demographics (age, BMI), preoperative laboratories (hemoglobin, albumin, lymphocyte, platelet, CA-125), the derived HALP score, operative time, intraoperative ascites volume, histology, FIGO 2014 stage, and the cytoreductive outcome label (MCR/OCR/SCR; primary endpoint: MCR vs non-MCR). HALP is reported both on the g/L, /L scale; and with g/dL and 10³/µL (halpskorcarpiyuz), the numerical value equals 100 × (Hb[g/dL] × Alb[g/dL] × lymphocyte[10³/µL] / platelet[10³/µL]). The deposit includes files to reproduce summary tables and ROC analyses. All data are de-identified: direct identifiers are removed. The study was approved by the institutional ethics committee (Approval No. AEŞH-EK1-2024-398; 08 May 2024). Please cite this DOI and the associated article when using the dataset.本数据集包含去标识化的患者个体层面数据，以及支撑论文《HALP评分对晚期上皮性卵巢癌最大细胞减灭术的预测价值》的SPSS语法文件。数据于2022年10月至2024年4月在单家妇科肿瘤中心连续收集，纳入140例行初始细胞减灭术的患者。变量涵盖人口学特征（年龄、体重指数BMI）、术前实验室指标（血红蛋白、白蛋白、淋巴细胞计数、血小板计数、CA-125）、衍生HALP评分、手术时长、术中腹水量、组织学类型、FIGO 2014分期，以及细胞减灭术结局标签（MCR/OCR/SCR；主要终点为MCR与非MCR的对比）。HALP评分同时以g/L、/L单位报告，亦以g/dL和10³/µL为单位（halpskorcarpiyuz），其计算公式为：数值=100×(Hb[g/dL]×Alb[g/dL]×淋巴细胞计数[10³/µL]/血小板计数[10³/µL])。本数据集附带可复现汇总表与ROC（受试者工作特征）分析的相关文件。所有数据均已完成去标识化处理：直接识别信息已全部移除。本研究已获得机构伦理委员会批准（批准号：AEŞH-EK1-2024-398；2024年5月8日）。使用本数据集时，请引用本DOI及相关联的学术论文。